This page is available in multiple languages
Select Language

Kiadis Pharma

Back

Kiadis Pharma sounds the gong in Amsterdam

Kiadis Pharma (ticker symbol: KDS), received this year’s tech 40 label from Euronext. Companies with the Tech 40 label are young technology companies listed on Euronext markets and operating in life sciences, eco-industries or TMT. An independent group of European experts selected the first 40 on the basis of their business, financial and stock market performance.

Kiadis Pharma is a clinical stage biopharmaceutical company focused on research, development and future commercialisation of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders.

For more information: www.kiadis.com

Download photo